Jupiter Neurosciences (JUNS) awards 100,000 stock options to director Hemmerly

Rhea-AI Filing Summary

Jupiter Neurosciences director Nicholas H. Hemmerly received a grant of stock options covering 100,000 shares of Common Stock. The options have an exercise price of $0.2783 per share and expire on June 2, 2036. They were granted under the company’s 2025 Equity Incentive Plan and vest over three years beginning on September 2, 2026, in equal quarterly installments, subject to his continued service through each vesting date. Following this grant, Hemmerly holds options for 100,000 underlying shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hemmerly Nicholas H.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	100,000	$0.00	--

Holdings After Transaction: Stock Option — 100,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 100,000 options Exercise price: $0.2783 per share Expiration date: June 2, 2036 +1 more

4 metrics

Stock options granted 100,000 options Grant to director Nicholas H. Hemmerly

Exercise price $0.2783 per share Stock option exercise price

Expiration date June 2, 2036 Option term under 2025 Equity Incentive Plan

Underlying shares 100,000 shares Common Stock covered by options

Key Terms

Stock Option, 2025 Equity Incentive Plan, vest over three years, Common Stock

4 terms

Stock Option financial

"security_title: "Stock Option""

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

2025 Equity Incentive Plan financial

"The options were granted under the Issuer's 2025 Equity Incentive Plan."

vest over three years financial

"The options vest over three years commencing from September 2, 2026"

Common Stock financial

"underlying_security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hemmerly Nicholas H.

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HYWAY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.2783	06/02/2026		A		100,000		(1)	06/02/2036	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. The options were granted under the Issuer's 2025 Equity Incentive Plan. The options vest over three years commencing from September 2, 2026 in equal quarterly installments subject to continued service through each vesting date.

	/s/ Nicholas H. Hemmerly	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did JUNS director Nicholas H. Hemmerly report in this Form 4?

Nicholas H. Hemmerly reported receiving stock options for 100,000 shares of Jupiter Neurosciences Common Stock. The grant represents equity-based compensation rather than an open-market purchase or sale of existing shares.

What is the exercise price of the new JUNS stock options?

The granted stock options have an exercise price of $0.2783 per share. This is the price at which Hemmerly can buy Jupiter Neurosciences Common Stock once the options vest and before they expire, assuming he remains in service.

How do the JUNS options granted to Hemmerly vest over time?

The options vest over three years starting on September 2, 2026, in equal quarterly installments. Vesting is conditioned on Hemmerly’s continued service through each vesting date, aligning his compensation with longer-term involvement at Jupiter Neurosciences.

When do Nicholas H. Hemmerly’s JUNS stock options expire?

The stock options expire on June 2, 2036. Hemmerly can generally exercise vested options any time before that expiration date, subject to plan terms and his continued eligibility under the 2025 Equity Incentive Plan.

How many Jupiter Neurosciences shares are covered by Hemmerly’s options after this grant?

After this grant, Hemmerly holds options linked to 100,000 shares of Jupiter Neurosciences Common Stock. These represent potential future ownership if he chooses to exercise the options once they vest and pays the exercise price.

Under which plan were the new JUNS stock options granted?

The options were granted under Jupiter Neurosciences’ 2025 Equity Incentive Plan. This plan provides equity-based awards, such as stock options, to directors and other participants as part of their overall compensation and incentive structure.